Cannabis Banking Is Still Broken. This Credit Union Built Around It.
In April 2026, the federal government moved medical cannabis to Schedule III of the Controlled Substances Act, the most significant change to marijuana’s federal status in more than 50 years. Over the summer, a Drug Enforcement Administration hearing took up the larger question of whether adult-use cannabis should follow, wrapping in mid-July with a recommendation […]
How Cannabis Companies Can Take Advantage Of The Research And Development Tax Credit Under Federal Rescheduling (Op-Ed)
“Cannabis companies should consider various pitfalls to ensure not only legal compliance, but to maximize potential benefits.” By Meeren Amin, William Bogot and Douglas W. Charnas, Fox Rothschild LLP With rescheduling of medicinal marijuana and potential relief coming for recreational use, cannabis companies should be aware of tax benefits available to the industry. One such […]